Parallax Volatility Advisers’s CareDx CDNA Stock Holding History

Parallax Volatility Advisers’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-40,000	Closed	-$1.15M	–	2972
2018 Q3	$1.15M	Buy	+40,000	New	+$749K	﹤0.01%	1219

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Parallax Volatility Advisers's CDNA Position: Q2 2019 in Review

Parallax Volatility Advisers sold out of CareDx (CDNA) in Q2 2019, closing a stake of 4,377 shares — an estimated $140K sold.

Parallax Volatility Advisers first reported a position in CDNA in Q3 2018 and held it in 2 quarters. The position peaked at $138K in Q1 2019. 182 funds tracked by Wall St. Rank hold CDNA as of Q2 2019.

Parallax Volatility Advisers reported no remaining CareDx position as of Q2 2019 after selling out during the quarter.
Parallax Volatility Advisers sold 4,377 CareDx shares in Q2 2019, an estimated $140K.
Parallax Volatility Advisers first reported a position in CareDx in Q3 2018 and held it in 2 quarters.
Parallax Volatility Advisers's CareDx position peaked at $138K in Q1 2019.
182 funds tracked by Wall St. Rank held CareDx as of Q2 2019.

Based on Parallax Volatility Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.